These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12676791)

  • 21. Homeostatic γδ T Cell Contents Are Preserved by Granulocyte Colony-Stimulating Factor Priming and Correlate with the Early Recovery of γδ T Cell Subsets after Haploidentical Hematopoietic Stem Cell Transplantation.
    Bian Z; Xu LP; Fu Q; Huo M; Liu L; Zhao X; Huang XJ; Liu J
    Biol Blood Marrow Transplant; 2018 Feb; 24(2):252-259. PubMed ID: 29061533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granulocyte colony-stimulating factor perturbs lymphocyte mitochondrial function and inhibits cell cycle progression.
    Rutella S; Rumi C; Pierelli L; Morosetti R; Sica S; Bonanno G; Scambia G; Leone G
    Exp Hematol; 2000 Jun; 28(6):612-25. PubMed ID: 10880747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model.
    Hartung G; Zeis M; Glass B; Dreger P; Steinmann J; Schmitz N; Uharek L
    Bone Marrow Transplant; 2003 Jul; 32(1):49-56. PubMed ID: 12815478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the content and subpopulations of CD3 and CD34 positive cells in bone marrow harvests and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors.
    Hassan HT; Stockschläder M; Schleimer B; Krüger W; Zander AR
    Transpl Immunol; 1996 Dec; 4(4):319-23. PubMed ID: 8972563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional G-CSF pathways in t(8;21) leukemic cells allow for differentiation induction and degradation of AML1-ETO.
    Da Silva N; Meyer-Monard S; Menot ML; Parrado A; Lebel A; Balitrand N; Fenaux P; Micléa JM; Rousselot P; Degos L; Dombret H; Chomienne C
    Hematol J; 2000; 1(5):316-28. PubMed ID: 11920209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Significance of donors treatment with combination of recombinant human interleukin-11 and recombinant human granulocyte-colony stimulating factor in reduction of incidence of lethal grafts versus host disease after allogeneic bone marrow transplantation].
    Zhao J; Zhao XY; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2497-502. PubMed ID: 16321278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Granulocyte colony-stimulating factor produces a decrease in IFNgamma and increase in IL-4 when administrated to healthy donors.
    Rodríguez-Cortés O; Vela-Ojeda J; López-Santiago R; Montiel-Cervantes L; Reyes-Maldonado E; Estrada-García I; Moreno-Lafont MC
    J Clin Apher; 2010; 25(4):181-7. PubMed ID: 20818712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of the in vivo application of granulocyte colony-stimulating factor on NK cells in bone marrow and peripheral blood.
    Yu XX; Han TT; Xu LL; Chang YJ; Huang XJ; Zhao XY
    J Cell Mol Med; 2018 Jun; 22(6):3025-3034. PubMed ID: 29575692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of G-CSF in adaptive immunity.
    Franzke A
    Cytokine Growth Factor Rev; 2006 Aug; 17(4):235-44. PubMed ID: 16807060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-17-producing T cells contribute to acute graft-versus-host disease in patients undergoing unmanipulated blood and marrow transplantation.
    Zhao XY; Xu LL; Lu SY; Huang XJ
    Eur J Immunol; 2011 Feb; 41(2):514-26. PubMed ID: 21268020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential T cell subsets and cytokine profile between steady-state and G-CSF-primed bone marrow and its association with graft-versus-host disease.
    León-Rodríguez E; Rivera-Franco MM; Gómez-Martín D; Romo-Tena J; Juárez-Vega G; Merayo-Chalico J; Alcocer-Varela J
    Leuk Res; 2017 Dec; 63():47-52. PubMed ID: 29101827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulation of Stat5 by granulocyte colony-stimulating factor (G-CSF) is modulated by two distinct cytoplasmic regions of the G-CSF receptor.
    Dong F; Liu X; de Koning JP; Touw IP; Hennighausen L; Larner A; Grimley PM
    J Immunol; 1998 Dec; 161(12):6503-9. PubMed ID: 9862674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms for T cell tolerance induced with granulocyte colony-stimulating factor.
    Yang JZ; Zhang JQ; Sun LX
    Mol Immunol; 2016 Feb; 70():56-62. PubMed ID: 26703218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Granulocyte colony-stimulating factor (G-CSF)-mediated signaling regulates type IV collagenase activity in head and neck cancer cells.
    Sugimoto C; Fujieda S; Sunaga H; Noda I; Tanaka N; Kimura Y; Saito H; Matsukawa S
    Int J Cancer; 2001 Jul; 93(1):42-6. PubMed ID: 11391619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained receptor activation and hyperproliferation in response to granulocyte colony-stimulating factor (G-CSF) in mice with a severe congenital neutropenia/acute myeloid leukemia-derived mutation in the G-CSF receptor gene.
    Hermans MH; Antonissen C; Ward AC; Mayen AE; Ploemacher RE; Touw IP
    J Exp Med; 1999 Feb; 189(4):683-92. PubMed ID: 9989983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Granulocyte colony-stimulating factor directly affects human monocytes and modulates cytokine secretion.
    Saito M; Kiyokawa N; Taguchi T; Suzuki K; Sekino T; Mimori K; Suzuki T; Nakajima H; Katagiri YU; Fujimura J; Fujita H; Ishimoto K; Yamashiro Y; Fujimoto J
    Exp Hematol; 2002 Oct; 30(10):1115-23. PubMed ID: 12384141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of G-CSF-stimulated donor marrow on engraftment and incidence of graft-versus-host disease in allogeneic bone marrow transplantation.
    Ji SQ; Chen HR; Xun CQ; Wang HX; Pan SP; Xiao MH
    Clin Transplant; 2001 Oct; 15(5):317-23. PubMed ID: 11678957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bivalent binding and signaling characteristics of Leridistim, a novel chimeric dual agonist of interleukin-3 and granulocyte colony-stimulating factor receptors.
    Monahan JB; Hood WF; Welply JK; Shieh JJ; Polazzi JO; Li X
    Exp Hematol; 2001 Apr; 29(4):416-24. PubMed ID: 11301181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Administration of leukemic granulocyte colony-stimulating factor to donors: the changes in donor bone marrow cell composition and the transplantation outcome].
    Ji S; Chen H; Wang H; Yan H; Pan S
    Zhonghua Nei Ke Za Zhi; 2001 Dec; 40(12):834-7. PubMed ID: 16206675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased G-CSF responsiveness of bone marrow cells from hematopoietic cell phosphatase deficient viable motheaten mice.
    Tapley P; Shevde NK; Schweitzer PA; Gallina M; Christianson SW; Lin IL; Stein RB; Shultz LD; Rosen J; Lamb P
    Exp Hematol; 1997 Feb; 25(2):122-31. PubMed ID: 9015212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.